Metastatic Breast Cancer Cells

SABCS Video Perspectives

Healio spoke with experts in breast cancer about what to expect from SABCS 2019, developments in diagnosis, advances in treatments, pivotal trials and more highlights from the meeting.

Virginia Kaklamani, MD, DSc

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • Virginia Kaklamani, MD, DSc

      What should clinicians expect from attending SABCS?

    • Virginia Kaklamani, MD, DSc

      Which research presentations do you anticipate being highlights of the meeting?

    • Virginia Kaklamani, MD, DSc

      What are you most excited for that’s happening at the meeting?

    • Virginia Kaklamani, MD, DSc

      What impact does SABCS usually have on your practice?

    • Virginia Kaklamani, MD, DSc, is the leader of the Breast Oncology Program at the University of Texas Health San Antonio’s MD Anderson Cancer Center and co-director of the San Antonio Breast Cancer Symposium.

      In this video, Kaklamani discusses:

      • what to expect from attending SABCS 2019;
      • pivotal trials to be presented;
      • exciting happenings; and
      • how the meeting affects clinical practice.